Background: Extensive global experience shows that rabies pre-exposure prophylaxis (PrEP) through vaccination is effective and well tolerated, yet many travellers opt not to be vaccinated when travelling to rabies-endemic countries. Previous research has identified several factors influencing the choices travellers make to reduce the risk of rabies, including cost, time constraint and perspective on the importance of vaccination. The objectives of this study were to assess travellers' awareness of rabies and advice-seeking attitudes and to evaluate travel clinics practices regarding rabies pre-travel advice. Methods: We surveyed individuals aged 18-65 years residing in the UK, Germany, Canada and Sweden who had travelled to rabies-endemic countries between 2013 and 2016 and defined this as the rabies visit-risk sample. The first 850 respondents from the visit-risk sample who had undertaken pre-defined at-risk activities (e.g. contact with animals during the trip) completed an additional 15-min online questionnaire and were included in the activity-risk subsample. We also interviewed travel clinic personnel using a 25-min online or phone questionnaire. Results: The visit-risk sample included 4678 individuals. Many sought pre-travel health information online (33%) or talked to a family doctor (24%). Within the activity-risk subsample, 83% of travellers were aware of at least a few basic facts about rabies, and 84% could identify at least one correct rabies prevention measure; 49% were aware of a rabies vaccine, however, only 8% reported receiving PrEP vaccination within the past 3 years. Among 180 travel clinic respondents, 21% reported recommending PrEP against rabies to all travellers to rabies-endemic countries. Travel clinics estimated that 81% of travellers complete their travel vaccination schedules and reported sending reminders by e-mails (38%), text (38%), phone calls (37%) or by using vaccination cards (37%). Conclusions: These findings suggest that although travellers had frequently heard of rabies, awareness of the risks of this serious infectious disease was relatively low.
Background
Rabies is a viral disease endemic in more than 150 countries and territories, with the highest risk of exposure in Asia and Africa. [1] [2] [3] Rabies is usually transmitted to humans from bites and licks from infected dogs, although rabies can infect a wide variety of mammals, including bats. 3 However, dogs are the principal host in Asia, parts of America and large parts of Africa. 3 After clinical symptoms manifest in humans, rabies is almost always fatal. 4 Worldwide, there are an estimated 60 000 fatal cases of rabies each year, with about 99% of cases occurring in Africa and Asia. 1, 3 Many tourists travel to destinations where rabies prevalence is still high and an overall increase in international arrivals has been reported 5 : between January and April 2018, international arrivals increased by 8% in Asia, 6% in Africa and 3% in the Americas compared with the same period in 2017. 6 Rabies exposure poses a risk particularly to travellers to Southeast Asia, including expatriates. 7 It has been reported that tourists are inadequately informed about this life-threatening infection; 8 in several endemic countries, effective vaccination of dogs is not fully implemented and it is therefore essential to avoid contact with unfamiliar dogs. Because human rabies has also been reported following exposure to non-human primates, 9 travellers
should also avoid any interactions with these. If bitten, travellers should be clearly informed of the need to seek immediate healthcare to evaluate the need for post-exposure prophylaxis (PEP), in line with official guidelines: wound washing with soap, water and disinfectant and multiple-dose vaccination with or without rabies immune globulin administration. Pre-exposure prophylaxis (PrEP) is also recommended for travellers and consists of three doses of vaccine given within 3 or 4 weeks, according to manufactures' recommended schedule; although recently updated recommendations from the World Health Organization (WHO) suggest that, based on review of the available evidence, intradermal PrEP can be shortened to 1 week with two-visit regimens. 4 If
PrEP has been administered and the immune system is primed before exposure, PEP is reduced to wound washing and two doses of vaccine without rabies immune globulin. 4 Although global experience with vaccines against rabies show that PrEP is immunogenic and well tolerated, an estimated 70% of travellers to rabies-endemic countries do not receive PrEP vaccine pre-travel. 10 We conducted a questionnaire-based, online survey to assess travellers' awareness of rabies and advice-seeking attitudes and to evaluate travel clinics practices regarding rabies pre-travel advice.
Methods
We conducted an online survey between October and November 2016 with participants from Canada, Germany, Sweden and UK. All respondents were recruited from panels of individuals who had previously agreed to take part in online market research. The survey included travellers to rabies-and/or TBE (tick-born encephalitis)-endemic regions. In this paper, we present the results of the rabies survey.
Respondents aged 18-65 years, who had travelled to rabiesor TBE-endemic countries in the prior 3 years, were invited to complete a 5-min questionnaire (visit-risk sample) and a subset who met criteria for activities with high risk for rabies were selected to take part in an additional 15-min survey (activityrisk sample). High-risk activities were trips to rabies-endemic countries lasting longer than 1 month, or a visit during which the individual had limited access to healthcare or had contact with animals. Eligibility of healthcare providers (HCPs) was assessed via a screening questionnaire, with the inclusion criteria: at least 3-year experience of working in a travel clinic, a minimum of 10 h per week spent working in a travel clinic (10 h per month in Sweden) and responsibility for advising on, and making decisions about, travel vaccination, administering at least five (for the UK and Germany) or three (for Sweden and Canada) rabies vaccines a month.
Briefly, the visit-risk sample answered a series of closed-end questions based on travel destinations and preparation for trips and activities, including knowledge of travel clinics, and awareness of rabies disease and risk, as well as knowledge of preventive measures, including vaccination. The activity-risk subsample proceeded to answer additional closed-and open-ended questions addressing rabies' risk behaviour and drivers and barriers to vaccination. The travel clinic's questionnaire assessed practices regarding pre-travel advice, including risk assessment and prevention.
A sample size of >4000 individuals (1000 in each country) for the visit-risk survey and 850 individuals (250 in Canada, Germany and the UK and 100 in Sweden) for the activity-risk survey was planned. Analyses were descriptive and were performed separately for travellers' and travel clinic data. A more detailed explanation can be found in Supplement 1.
Results

Visit-risk sample
Of the 22 910 eligible individuals, 4678 had visited a rabiesendemic country and completed the visit-risk survey (visit-risk sample) (Figure 1 ). Demographic and socio-economic characteristics for the visit-risk sample are presented in Supplement 2.
The most visited rabies-endemic countries were Turkey (20%), Mexico (16%), Thailand (12%), Poland (11%) and Croatia (9%). Note: *the first 850 travellers who had visited a rabies-endemic country and had completed the visit-risk questionnaire and met activity-risk eligibility criteria were invited to complete the activity-risk questionnaire.
In the visit-risk sample, respondents most commonly searched for pre-travel health advice online (33%). Between 20% and 24% of respondents talked to either their family doctor or family/friends who had visited the same country. Smaller proportions read a guide book (16%) or visited a travel clinic (12%), a pharmacist (12%) or a healthcare centre/private clinic/ occupational health clinic (13%). Approximately 16% said they had a good knowledge of rabies, while others indicated they knew basic facts (35%) or had some understanding of rabies (32%); only a small proportion (4%) had never heard of the disease. Less than half of the visit-risk travellers (43%) were aware of a rabies vaccine, with awareness being the lowest in Sweden (35%) and the highest in Germany (53%).
Activity-risk subsample
Among the rabies visit-risk sample, 81% (850 travellers) took part in a high-risk activity and completed the activity-risk questionnaire ( Figure 1 ). While travelling, 48% had spent part or the entire trip in remote locations with difficult access to hospitals/medical centres, 55% had contact with animals and 59% spent ≥4 weeks in a rabies-endemic country. Demographics and socio-economic characteristics for the activity-risk subsample are shown in Table 1 .
The majority (54%) of the visit-risk respondents reported some understanding or good knowledge of rabies. Only 14% reported having felt at risk of rabies on at least one occasion and 22% never felt at risk. Travellers felt at risk of rabies most frequently when travelling to South America, Asia and Africa compared with Europe or North and Central America. However, 26% of travellers to Africa reported not having taken any preventative measures, compared with16% of travellers to North and Central America (Table 2) .
Approximately 90% of activity-risk respondents could identify at least one correct prevention measure; most travellers (78%) were aware of the need to avoid contact with wild or stray animals, to wash the wound when bitten or scratched (47%) or to have the PEP vaccination (40%). Avoiding contact with domestic animals was identified by 43% of respondents, and only 27% were aware of PrEP vaccination. Those with a greater awareness of rabies were also those more likely to have taken appropriate prevention measures; however, 16% of the activity-risk sample did not take any correct steps to minimize their risk ( Figure 2 ).
Almost half of the respondents (49%) were aware of a rabies vaccine, with awareness being the lowest in Sweden (35%) and the highest in Germany (60%). Similar proportions of respondents were aware of rabies PrEP (29%) and PEP (27%) vaccination. In Sweden, awareness of rabies PrEP and PEP vaccination regimens was 8 and 7%, respectively, whereas in the other three countries, 31-32% and 28-35% were aware of PrEP and PEP, respectively. Most travellers who were aware of PrEP vaccination had heard of it from their doctor (47%). Additional sources were travel clinics (29%), online searches (26%), friends/family (25%) and the general media (17%).
Overall, 17% of the activity-risk subsample reported having previously received a rabies vaccine; 11% had been vaccinated in the 3 years before the survey, with most (8%) having received PrEP rather than PEP (3%). Following a HCP's [mainly a doctor (54%) or a travel clinic (35%)] advice was the main reported reason for being vaccinated, for 69% of travellers. This was followed by the traveller's risk awareness (41%), their 'own peace of mind' (24%), limited access to medical care during the trip (20%) or plans to engage in high-risk activities (18%) while travelling. Among rabies-vaccinated travellers, 60% reported booking follow-up appointments as a reminder of the vaccination schedule (Table 3) . Travellers cited a low sense of risk (42%), not having thought about it (29%) or not being prompted to have it (25%) as the leading reasons for not getting vaccinated (Table 4) .
Travel clinics' sample
A total of 180 travel clinic respondents were included in the survey (47 from Canada, 33 from Sweden and 50 from each Germany and the UK). According to these respondents, 39% of travellers visiting the clinics were informed about travel health risks, and 60% were aware of the travel vaccinations needed (with 29% being very well informed and 31% looking for confirmation).
When assessing risks associated with travel, most travel clinic HCPs (72%) reported using their personal judgement.
Others used a list of mandatory questions (69%), a health risk questionnaire/form (61%) or online/ electronic tools (35%). Most travel clinics used questions or tools based on guidelines from the WHO (66%) or national health organizations (64%). Only 37% conducted risk assessments based on guidelines developed by the clinic. Most questions asked to travellers when completing a personalized travel risk assessment were related to the trip (e.g. duration, location, planned activities) as well as medical history (Supplement 3).
When asked to prioritize vaccines recommended for travellers at risk of all conditions, most HCPs selected vaccines against yellow fever (62%), hepatitis A (57%) and hepatitis B (56%), followed by rabies (41%), typhoid fever (34%), meningitis (32%) and cholera (19%).
The main reasons HCPs recommended PrEP before travel were the likelihood of contact with animals (59%), restricted access to medical care (48%), remote travel (46%) or travel to a known risk area (46%). Only 21% of HCPs recommended vaccination to all travellers visiting a high-risk country. Most (74%) supported their PrEP recommendation with arguments around the risks and severity of the disease, with only 37% stressing it is fatal and others giving information about risks and complications (26%) or mentioning the severity of the disease (14%). Most respondents (59%) would recommend PrEP rather than relying on PEP after exposure only (15%). In general, HCPs reported that 81% of travellers complete their travel vaccination schedules and most clinics use several types of reminders to encourage full adherence. Booking follow-up appointments was reported by 50% of HCPs. Other reminders included email (38%), text (38%), phone (37%) or use of vaccination cards (37%) ( Table 3) .
Travel clinics reported that the cost of the vaccine (61%), low risk perception (56%) and a lack of time (52%) were the main reasons for travellers not getting the vaccine (Table 4) .
Discussion
In our study, among 4678 travellers to rabies-endemic countries in the past 3 years, the majority (83%) were aware of at least a few basic facts about rabies but awareness of their own risk to contract and how to prevent this serious infectious disease was relatively low. A perceived lack of risk was most frequently stated as the reason for not being vaccinated among activity-risk travellers, although travel clinic HCPs perceived cost to be the main barrier.
Travellers in the visit-risk sample were most likely to look online for information about travel health or talk to a family doctor. The results suggest that traditional sources of information such as doctors, pharmacists and healthcare centres were secondary to Internet-based sources of traveller information, and that travellers tended to look independently for information rather than ask for it. Further investigation might be needed on the sources of online information that travellers view and/or trust to assess the accuracy and presentation of rabies risks and how best to prevent this potentially fatal disease. In the activity-risk subsample, over half of the travellers spent ≥4 weeks in a rabies-endemic country, and half reported spending time with limited access to medical care, yet despite this, only 22% reported ever feeling concerned about rabies. This sense of risk and awareness of rabies PrEP vaccination is consistent with previous reports of travellers which showed that the uptake of rabies vaccine was relatively low compared with hepatitis A, typhoid and yellow fever. [11] [12] [13] We found that perceptions of the risk of rabies varied widely dependent on the travellers' country of origin with Germans being the most likely to have ever felt at high risk of rabies (22%). Awareness of precautions against rabies was also the highest in Germany. The rabies' risk perception also varied with the visited region and the results of our study suggested that travellers are more likely to feel at risk when visiting Asia and Africa compared with areas that could be perceived more as 'home territory' such as Europe or Central America. This was also reflected in an overall awareness of the need to avoid wild animals to reduce the risk exposure to rabies, but a lower awareness of the risk of rabies associated with domestic animals, possibly due to the fact that for example in Europe rabies in dogs has been mostly eliminated. Across all countries, half of the activity-risk subsamples were aware of a rabies vaccine, yet the rate of PrEP vaccination in the past 3 years was very low (8%). This rate is however consistent with previous reports from a study in international travellers attending a travel clinic in the Netherlands (7.8%) 14 or travellers from the USA travelling for 1 month or more in countries with a strong recommendation for rabies (2%). 15 In our study, awareness of rabies PrEP and PEP vaccination in Sweden was relatively low compared with the other countries. This is similar with data published by Angelin et al., which sampled people attending a travel clinic in Sweden. 11 Although a third of the population stated that Thailand was the travel destination, only 0.5% reported being vaccinated against rabies, compared with 79.4% for hepatitis A, 12.2% for typhoid and 8.9% for yellow fever. The authors highlighted the need to increase rabies vaccination coverage among Swedish travellers to protect against rabies exposure. 11 Finally, among the activity-risk subsample,
we found approximately a third (28%) of the activity-risk subsample knew that PrEP consisted of three vaccine doses, although 59% of travellers, who had received PrEP, reported that the importance of receiving all doses had been made extremely clear. This suggests that greater awareness about the role and administration of rabies vaccine may be warranted for travellers.
Our results are consistent with previous surveys of travellers that reported a perception of low risk of rabies exposure as the main reason for declining vaccination. [11] [12] [13] [16] [17] [18] [19] More specifically, in a US study of 2650 travellers who were eligible for PrEP, 44% refused vaccination, with the majority citing lack of concern as the reason. 17 Studies from Demark and Switzerland reported similar findings. 12, 13 In a US records-based study of travellers that received PEP, it was estimated that about 0.4% of travellers to rabies-endemic countries are at risk of an animal bite. 20 In another study of travellers to Southeast Asia, during an average stay of 30 days, among 870 backpackers, 31 (3.6%) reported being licked and 6 (0.7%) being bitten by an animal. 21 Although the overall risk of exposure is low, spending time outdoors or in remote rural areas increases the chance of contact with wild animals and there is a need for increased awareness of the preventative measures that can be taken to avoid rabies, including the need to seek healthcare in case of contact with suspect animals, especially for children who might not report having been bitten. This need is supported by the large proportion of travellers in our study who reported that they had never thought about rabies vaccination or had been advised to get vaccinated.
The main limitation of the traveller survey was the selection bias associated with a self-selected sample recruited from an online panel, meaning that the populations cannot be considered as nationally representative. Selection bias was also a limitation of the travel clinic survey. Finally, an additional limitation was that feedback during the recruitment phase with travel clinic respondents suggested that the concept of 'travel clinics' does not exist in Sweden, rather travellers are more likely to attend vaccination sessions at their local health centre. Recall bias was a limitation of both surveys.
Conclusions
Our study showed that the perceived risk of exposure to rabies for travellers to endemic regions was low even though the majority of travellers claimed to have sourced advice online or from a HCP. Lack of perceived risk was most frequently stated as the reason for not being vaccinated among travellers, whereas HCPs stated that cost was the main barrier. There was uncertainty among travellers about the risk of being exposed to rabies from wild animals and the need for precautions in countries that are dog rabies-free. This suggests that the type of information and the methods of communication about the risk of rabies, such as online or discussion with HCPs, should be evaluated to identify gaps and to validate travel clinic protocols to ensure that travellers receive accurate and impactful advice.
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